David Windley
Stock Analyst at Jefferies
(3.55)
# 893
Out of 4,996 analysts
196
Total ratings
66.06%
Success rate
13.4%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $496.79 | -9.42% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $179.56 | +25.31% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $163.79 | +6.84% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $8.68 | +9.45% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $148.56 | +31.26% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $249.08 | +5.59% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $2.03 | +35.47% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $34.86 | +74.99% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $18.42 | -34.85% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $254.95 | -0.76% | 18 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $286.17 | +47.46% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $191.98 | +54.70% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $481 → $647 | $344.08 | +88.04% | 26 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $1.38 | +171.74% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $318.61 | +89.57% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $441.12 | -14.99% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.82 | -2.02% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $290.27 | -6.98% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.80 | +31.36% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $261.52 | +104.96% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $25.66 | +13.02% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $8.16 | +2,939.22% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.46 | - | 5 | Oct 9, 2017 |
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $496.79
Upside: -9.42%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $179.56
Upside: +25.31%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $163.79
Upside: +6.84%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $8.68
Upside: +9.45%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $148.56
Upside: +31.26%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $249.08
Upside: +5.59%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $2.03
Upside: +35.47%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $34.86
Upside: +74.99%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $18.42
Upside: -34.85%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $254.95
Upside: -0.76%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $286.17
Upside: +47.46%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $191.98
Upside: +54.70%
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $344.08
Upside: +88.04%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.38
Upside: +171.74%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $318.61
Upside: +89.57%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $441.12
Upside: -14.99%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.82
Upside: -2.02%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $290.27
Upside: -6.98%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.80
Upside: +31.36%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $261.52
Upside: +104.96%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $25.66
Upside: +13.02%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $8.16
Upside: +2,939.22%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.46
Upside: -